Neurogait
Using AI to screen Curable Dementia and other Neurological disease
StartupNeurogait is a Ra'anana-based startup in the Health Tech & Life Sciences sector, established in 2019. Using AI to screen Curable Dementia and other Neurological disease. Neurogait was founded by Eyal Fruchtman and Ben Francke. Key investors include Lisa Ansell. The company has 1-10 employees. Core technologies: Sensing, Artificial Intelligence, Deep Learning, Computer Vision, Machine Learning.
The company follows a B2B2C/B2B business model. Product stage: Beta.
- StageSeed
- ProductBeta
- ModelB2B2C, B2B
- Employees1-10
- HQRa'anana
- DistrictCenter District
- Last RoundUndisclosed
- Lisa AnsellLead
Eyal FruchtmanCo-founder & CEO
Ben FranckeCo-founder
1 article covered by sources including www.technology-innovators.com.
What does Neurogait do?
Neurogait is developing AI based clinical screening for curable dementia, Parkinson's and other neurodegenerative Disease. It has conducted a successful clinical trial in Sheba Medical center and is an innovative Partner of Sheba ARC Innovation arm. It is currently pursuing clinical pilots in the EU and is in the process of applying for an MDR CE as a type 2a Medical device.
Who founded Neurogait?
Neurogait was founded in 2019 by Eyal Fruchtman (Co-founder & CEO), Ben Francke (Co-founder).
What sector is Neurogait in?
Neurogait operates in Health Tech & Life Sciences, Medical Devices, Diagnostics Devices, Digital Healthcare, Digital Medical Diagnostics, with core technologies in Sensing, Artificial Intelligence, Deep Learning, Computer Vision, Machine Learning. Target customers: Healthcare & Life Sciences, Healthcare, Providers, Patients, Medical Devices Industry.
Where is Neurogait located?
Neurogait is based in Ranana, Israel, Center District.